INTRODUCTION
Despite long-standing controversies that hematopoietic stem cells (HSCs) are effective in treating nonhematopoietic diseases, several mechanisms have been proposed to provide tissue repair: cell replacement [1] , cell fusion [2] , and paracrine/contact interaction [3] . We previously reported that HSCs could correct a nonhematopoietic, multisystemic degenerative disorder, cystinosis, using a validated cystinosis mouse model (Ctns
) [4, 5] . Cystinosis is a lysosomal storage disorder due to intralysosomal accumulation of cystine in all tissues, leading to early lesions in kidney proximal tubules and eyes, and subsequently evolving into multiorgan failure including end-stage kidney disease, hypothyroidism, myopathy, and neuropathy [6] . The protein defective in cystinosis, cystinosin (CTNS gene), is a seventransmembrane proton-driven cystine transporter bearing two redundant lysosomal targeting signals [4, 7] . In Ctns 2/2 mice, stable engraftment of bone marrow-derived cells in all organs led to the dramatic reduction in tissue cystine levels in all organs and provided long-term kidney preservation [8] [9] [10] . Our recent data pointed to cross-correction, that is, transfer of a functional protein into adjacent deficient cells, as a possible mechanism [8] . However, while cross-correction has been amply demonstrated in several lysosomal storage disorders due to defective soluble lysosomal enzymes by secretion-recapture or enzyme replacement therapy [11] , this phenomenon has never been demonstrated for lysosomal transmembrane proteins. In this context, several questions were raised to explain the dramatic impact of HSC transplantation in cystinosis: (a) how do HSCs mediate rescue of nonhematopoietic diseased cells; (b) how can HSCs effectively restore a functional seven-transmembrane transporter in deficient cells; and (c) how can HSC-derived correcting factor(s) penetrate epithelia such as kidney proximal tubular cells (PTCs) that are surrounded by a tight continuous tubular basement membrane (TBM).
Intercellular transport of organelles including lysosomes can occur via tubular extensions mostly known as "tunneling nanotubes" (TNTs), initially reported in vitro [12] but also recently in vivo [13, 14] . TNTs are heterogeneous cell-connecting tubules that are composed of plasma membrane-bound extensions containing either F-actin alone (thin TNTs, <0.7 mm diameter) or F-actin and microtubules (thick TNTs, >0.7 mm diameter) [15] [16] [17] . Often >20 mm in length, TNTs can support long-distance vesicular trafficking in human macrophages [15] and are involved in pathogen spreading and intercellular communication [16, 18] . However, the mechanism of passage across two apposed plasma membranes remains mysterious, and three scenarios have been proposed: (a) transient membrane fusion; (b) organelle release at the nanotube tip and secondary capture by target cells; and (c) engulfment by the recipient cells of bulging nanotube tip with all included organelles ("snapping") [19] .
Epithelial basement membranes are specialized cellassociated extracellular matrix (ECM) sheaths that are produced, tightly enclose, and remodeled by epithelial cells [20] . In the kidney, the TBM is a continuous, thick, and dense barrier that strongly limits macromolecules and supramolecular structures to access the tubular cells from the interstitium. The stiffness of TBM is considered comparable to that of articular cartilage [21, 22] . However, ECM can be breached by invadopodia, these highly dynamic, actin-driven membrane protrusions that have the capacity to extend into extracellular matrix and recruit at their tip proteolytic activities such as membrane-type metalloprotease 1, MT1-MMP [23] . Invadopodia have been extensively studied in vitro using cancer cell lines in three-dimensional (3D) matrices and recently described in vivo in Caenorhabditis elegans [24] [25] [26] but their equivalent in mammalian organisms has still to be defined.
In this study, we demonstrated for the first time that transplanted HSCs led to cross-correction of a lysosomal transmembrane protein after differentiation into macrophages. In coculture with cystinotic fibroblasts, macrophages generated long TNTs acting as intercellular bridges supporting sustained bidirectional lysosomal exchange. In vivo, macrophage-derived tubular extensions resembling invadopodia penetrated the TBM and delivered directly CTNScontaining vesicles into PTCs, suggesting that TNTs and invadopodia are related devices. mice constitutively expressing the DsRed fluorescent protein under the control of the chicken b-actin promoter coupled with the cytomegalovirus immediate early enhancer as previously described [8] . All strains were bred continuously at University of California, San Diego (UCSD) including wild-type C57BL/6 mice and eGFPtransgenic mice (C57BL/6-Tg(ACTB-EGFP)1Osb/J, Jackson Laboratory). All protocols were approved by the AAALACAccredited Institutional Animal Care and Use Committee of UCSD.
MATERIALS AND METHODS

Mice
Cell Culture
Fibroblasts were generated from newborn skin biopsies of C57BL/6 wild-type (WT), Ctns 2/2 , DsRed WT, and DsRed Ctns 2/2 mice. They were maintained using high glucose DMEM (Dulbecco's modified Eagle's medium; Life Technologies, Carlsbad, CA, www.lifetechnologies.com) supplemented with 10% fetal bovine serum (FBS; Gibco, Life Technologies) and 1% penicillin/streptomycin (PenStrep; Gibco) at 37 C under 5% CO 2 .
Mononuclear phagocyte progenitor cells derived from femoral and tibial bone marrow of C57BL/6 WT and eGFPtransgenic mice were propagated in the presence of M-CSF. This macrophage growth factor is secreted by the murine L929 cells [27] and was used as L929 cell-conditioned medium [28] . Flushed bone marrow cells were incubated for 5 minutes in red blood cell lysis buffer. Cells were then passed through a 70-mm cell strainer (BD Biosciences, San Jose, CA, www. bdbiosciences.com) and plated at a density of 10 3 10 6 in a 10-cm dish in DMEM (Gibco), L929-conditioned media, and 1% penicillin-streptomycin-glutamine (Gibco). After 7-8 days, cells had become firmly adherent to the culture vessel and were fully differentiated. They were characterized by flow cytometry after staining with PECy7-conjugated murine anti-CD45 (BD Pharmingen, BD Biosciences), -CD11b, and -F4/80 antibodies (eBioscience, San Diego, CA, www.ebioscience. com).
The IC-21 macrophage cell line was obtained from American Type Culture Collection (Catalog #TIB-186) and cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco) supplemented with 10% FBS (Gibco) and 1% PenStrep at 37 C with 5% CO 2 incubation. These trypsin-sensitive cells were harvested into Dulbecco's phosphate buffered saline (PBS; Gibco) using a cell scraper (Fisher Scientific, San Diego, CA, www.fishersci.com). Mesenchymal stem cells derived from the eGFP-transgenic mice (eGFP-MSCs) were generated as described previously [9] .
Lentivirus Vector Generation and Production
The SIN-lentivirus vector, pCCL-EFS-X-WPRE (pCCL) was used for gene transfer [29] and contains the intron-less human Elongation Factor 1 alpha promoter (EFS; 242 bp) to drive the transgene expression [30] . The constructs pCCL-eGFP and pCCL-CTNS-eGFP containing the eGFP and the fusion CTNSeGFP cDNA, respectively, were previously reported [8] . pCCL-Lamp1-DsRed was generated as follows: Lamp1 was amplified from murine cDNA by PCR using the following primers containing the XhoI and BamHI restrictions sites:
0 (reverse). The PCR product was inserted in phase with DsRed by replacing CTNS in the pCCL-CTNSDsRed backbone using Xho-I HF and BamHI-HF (New England Biolabs, Ipswich, MA, www.neb.com) restriction sites. Infectious lentiviral particles were produced using the transient tritransfection procedure in human embryonic kidney 293T cells as previously described [8] .
Stable Transduction of Primary Fibroblasts, Primary Macrophages, and IC-21 Cell Line
Six-well plates were coated with Retronectin (20 ml/ml; Takara Bio, Madison, WI, www.takara-bio.com) following the 
Transwell and Coculture Assays
For transwell assays, Ctns 2/2 fibroblasts were plated at 1 3 10 5 cells per well in six-well plates (BD BioCoat, BD Biosciences). Ctns 2/2 fibroblasts, eGFP-MSCs, or eGFP-macrophages were plated over transwell inserts at 6 3 10 4 cells per well. After 14 days of separate coculture at 37 C, transwell inserts were removed and Ctns 2/2 fibroblasts were harvested using trypsin for cystine measurement.
For contact coculture assays, 4 3 10 5 DsRed Ctns
fibroblasts were plated with 1 3 10 5 Ctns 2/2 fibroblasts, eGFP-MSC, pCCL-CTNS-eGFP fibroblasts, or eGFP-macrophages in 10 cm culture dishes. Cells were incubated for 14 days at 37 C, harvested using trypsin, pelleted and resuspended in PBS with 2% FBS, and DsRed fibroblasts were separated using a BD FACS Aria-1 cell sorter prior to processing for cystine content measurement.
Cystine Content Measurement
Cells were resuspended in 150 ml N-ethylmaleimide and sonicated for 10 seconds at an amplitude of 2 on ice. Proteins were precipitated using 15% 5-sulfosalicylic acid dihydrate (Fluka Biochemika, Sigma-Aldrich, St. Louis, MO, www.sigma aldrich.com), resuspended in 0.1 N NaOH, and measured using the Pierce BCA protein assay kit (Pierce, Rockford, IL, www.piercenet.com). Cystine-containing supernatants were sent to the UCSD Biochemical Genetics laboratory for measurement by mass spectrometry as described previously [10] .
HSC Isolation, Transduction, and Transplantation
Bone marrow cells were flushed from the long bones of 6-8-week-old eGFP-transgenic mice and DsRed Ctns 2/2 mice. HSCs were isolated by immunomagnetic separation using antiSca1 antibody conjugated to magnetic beads (Miltenyi Biotec, Auburn, CA, www.miltenyibiotec.com). Sca1
1 HSCs from eGFP-transgenic mice (eGFP-HSCs) were directly transplanted by tail vein injection of 1 3 10 6 cells resuspended in 100 ml of PBS into DsRed Ctns 2/2 mice lethally irradiated (8 Gy) on the previous day. Sca1 1 HSCs isolated from DsRed Ctns 2/2 mice were transduced with pCCL-CTNS-eGFP as previously described [8] .
Scanning Electron Microscopy and Transmission Electron Microscopy
Contact cocultures of macrophages and fibroblasts on 12-mm glass coverslips were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3), buffer-washed, and postfixed in buffered 1% osmium tetroxide. For scanning electron microscopy (SEM), samples were extensively washed in buffer followed by distilled water, dehydrated in graded ethanol series, processed through a critical point dryer (Tousimis Autosamdri 815), and mounted onto SEM stubs with carbon tape. After sputter coating with iridium at 10 mA (EMS model 150T S), preparations were viewed with a Hitachi S-4800 SEM (Hitachi, Pleasanton, CA, www.hitachi.us). For transmission electron microscopy (TEM), glutaraldehyde-and osmium-fixed samples were buffer washed, treated "en bloc" with 0.5% tannic acid and 1% sodium sulfate, buffer washed, dehydrated in ethanol series, transitioned in 2-hydroxypropyl methacrylate, and embedded in LX112 (Ladd Research, Williston, VT, www.laddresearch.com). Pieces of the flat embedded resin containing cells were glued to a blank block face and 60-nm ultrathin sections were cut, mounted on copper slot grids coated with parlodion, and stained with uranyl acetate and lead citrate. Grids were examined in a Philips CM100 electron microscope (Field Emission Inc.) operating at 80 kV and images were collected using a Megaview III CCD camera (Olympus Soft Imaging Solutions GmbH). ) were manually counted using the "Tools-measure" feature of the software. The tracking of CTNS-eGFP-containing vesicles inside TNTs was performed using the "Track objects manually" feature in Volocity software. The velocities of vesicles moving in one continuous motion without stopping or slowing down were determined.
Live Confocal Microscopy and Image Analysis
Immunofluorescence Analysis
Cocultures of CTNS-eGFP macrophages and DsRed Ctns 2/2 fibroblasts were stained with 100 nM LysoTracker-Blue DND-22 (Life Technologies) added to prewarmed complete phenol redfree RPMI. Following incubation for 3 minutes at 37 C, the medium was replaced with fresh medium. CTNS-eGFP macrophages (50,000) were plated with equal number of Ctns 2/2 fibroblasts on collagen-coated 0.17 mm coverslips (Fisher Scientific). On day 3, these cocultures were stained with AlexaFluor647-phalloidin (1:100 for 30 minutes; Molecular Probes, Eugene, OR) and rat anti-mouse tubulin (1:600; Abcam, Cambridge, MA, www.abcam.com) followed by Cy5-conjugated goat anti-rat antibody (1:200; Life Technologies). Furthermore, cells were stained with 4 0 ,6-diamidino-2-phenylindole,dihydrochloride (DAPI) (1:500 for 5 minutes; Life Technologies), and coverslips were mounted with ProLong Gold antifade reagent (Life Technologies).
Tissues were fixed in 5% formaldehyde, equilibrated in 20% sucrose overnight, and frozen in Tissue-Tek Optimal Cutting Temperature buffer at 280 C (Sakura Finetek, Torrance, To visualize TNTs across basement membrane, kidneys were perfusion-fixed through the left ventricle with 4% formaldehyde, equilibrated overnight in 20% sucrose, and embedded in Tissue-Tek Optimal Cutting Medium (Sakura Finetek). Thick frozen sections (5 mm) were permeabilized with PBS/0.3% Triton X-100 for 5 minutes, incubated for 1 hour with 10% bovine serum albumin (BSA) (Fisher Scientific) and 3% milk to block nonspecific sites, then incubated overnight at 4 C with a combination of biotinylated Lotus Tetragonolobus (LT)-lectin (1:200; B-1325; Vector Labs, Burlingame, CA, www.vectorlabs.com), goat anti-GFP (1:250; ab-6673; Abcam), and rabbit anti-laminin (1:100; L9393; Sigma-Aldrich) in blocking buffer. After washing, sections were incubated with a combination of AlexaFluor 647 donkey anti-rabbit, AlexaFluor488 donkey anti-goat, and AlexaFluor 405 streptavidin (all from Life Technologies) for 1 hour at room temperature in 10% BSA/0.3% Triton X-100 (Promega, Madison, WI, www.promega.com), then mounted with Dako Faramount Aqueous Mounting Medium (Dako, Carpinteria, CA, www.dako.com). Z-stack images were acquired on a spinning disk confocal microscope using a Plan-Apochromat 3100 (NA 5 1.4) Oil DIC objective (Cell Observer Spinning Disk; Zeiss, Oberkochen, Germany, www.zeiss.com) and merged with AxioVision Rel 4.8.2.
Statistical Analyses
Significance of differences in TNT numbers and length was analyzed using Student's paired t test. One-way ANOVA was used to study significance of differences in cystine contents in transwell and contact coculture assays. All analyses were performed using PRISM 6 software (GraphPad Cary, NC, www. graphpad.com). p < .05 was considered as statistically significant.
RESULTS AND DISCUSSION
HSCs Differentiate into Macrophages After Transplantation
To elucidate the mechanism of HSC-mediated tissue repair, we developed a novel mouse model, in which Ctns 2/2 mice back-crossed on a DsRed background so as to ubiquitously express the DsRed reporter gene [8] were transplanted at 2 months of age with eGFP-expressing HSCs derived from eGFP-transgenic mice and analyzed 6 months later. This bifluorescent mouse model not only allows us to track the fate of transplanted HSCs in an in vivo setting but also enables sensitive identification and unequivocal discrimination of events such as fusion, differentiation, and transdifferentiation.
In this model, we demonstrated that most of the eGFP 1 HSCderived cells in the liver and kidney did not express DsRed (Supporting Information Fig. S1B, S1E ), thereby excluding cell fusion as the main mechanism for tissue repair. In these tissues, most eGFP 1 bone marrow-derived cells also expressed the macrophage marker F4/80 (Supporting Information Fig.  S1C , S1F), consistent with our previous suggestion that HSCderived cells differentiate into tissue-resident macrophages [8] [9] [10] . These data also excluded transdifferentiation of HSCs into tissue-specific cell types as mechanism for tissue repair in cystinosis and implied instead a paracrine mode of action.
Direct Cell:Cell Contact is Necessary for Cross-Correction in Cystinosis
To investigate in vitro the local communication events underlying cell-based therapy in cystinosis, we further used our mouse models as source of wild-type (WT) eGFPmacrophages, eGFP-mesenchymal stem cells (MSCs), and Ctns 2/2 DsRed fibroblasts for coculture experiments. Two mechanisms could account for the transfer of a transmembrane protein from donor to host cells: indirectly by shedding of microvesicles/exosomes [31] , or by direct cell:cell contact.
Other groups have reported that microvesicles shed by MSCs or by transduced insect cells containing cystinosin and/or its mRNA could lead to substantial decrease in cystinotic fibroblast cystine levels [32, 33] . We found that when eGFP-MSCs and eGFP-macrophages were cocultured with DsRed-Ctns
fibroblasts, cystine levels decreased by 75% in fluorescenceactivated cell-sorted (FACS) fibroblasts (Fig. 1A) . In contrast, when the two populations were physically separated using a transwell porous to microvesicles/exosomes [34] , cystine levels decreased only by 20% (Fig. 1B) . These findings suggested that direct cell:cell contact is the main pathway for cross-correction. Using confocal (Fig. 1C) and scanning electron microscopy (SEM) (Fig. 1D ) of eGFP-macrophages and DsRed Ctns 2/2 fibroblasts cocultures, we found that macrophages extended long TNTs (40 mm in average length) that established contact with the fibroblasts, which were strong enough to resist critical-point drying used for SEM (Fig. 1D) . Thus, TNTs were potential candidates for mediating cross-correction for cystinosin.
TNTs Mediate Cross-Correction by Transfer of cystinosin-Bearing Lysosomes
To determine whether TNTs could mediate the physical transfer of cystinosin-bearing vesicles from WT macrophages to cystinotic fibroblasts, we cocultured DsRed-Ctns 2/2 fibroblasts with a macrophage-like IC21-cell line, stably transduced to express cystinosin-eGFP fusion protein (CTNS-eGFP-IC21 macrophages). Time-lapse confocal microscopy revealed that vesicles containing cystinosin-eGFP could migrate along TNTs toward DsRed-Ctns 2/2 fibroblasts ( Fig. 1F and Supporting
Information Video S1A). LysoTracker staining identified these vesicles as late endosomes/lysosomes (Supporting Information  Fig. S2A ). Similar data were obtained with primary macrophages derived from Ctns 2/2 mice stably expressing cystinosin-eGFP (Supporting Information Video S1B).
Cystinosin-containing vesicles often stalled or reversed direction before moving forward again. Overall, cystinosincontaining vesicles migrated at an average speed of 1 mm/second (ranging from 0.45 to 1.67 mm/second; n 5 24 tracked vesicles). These features are classic attributes of microtubulebased saltatory motion [15] . By immunofluorescence, thick TNTs containing cystinosin-bearing vesicles were labeled with tubulin (Supporting Information Fig. S2B ). By TEM, sections of thick TNTs showed a dense microfilamentous sheath surrounding a central channel with various organelles including lysosomes and mitochondria and with visible microtubules (Fig. 1E) .
A major question remained: how are lysosomes bearing correcting functional cystinosin passed from one cytoplasm to the other? In our coculture system, we observed TNT tips to bulge, appose, and apparently merge with their target cell (Fig. 1C, 1D) . Furthermore, time-lapse imaging disclosed free vesicle passage between donor and recipient cytoplasm (Supporting Information Video S3). We also observed the tips of the tubular extensions to snap, thereby delivering a pool of cystinosin-containing lysosomes to the deficient cells ( Fig.  1G and Supporting Information Video S2A), a possibility previously suggested by Wang and Gerdes [19] . Many individual CTNS-containing lysosomes were present in the cytoplasm of the fibroblast (Fig. 1H) , probably released by further fission of the internalized pools (Supporting Information Video S2B). To the best of our knowledge, these data are the first evidence of TNT snapping supporting a cross-correction mechanism.
When Ctns 2/2 fibroblasts were replaced by DsRed-WT fibroblasts, the length of TNTs from eGFP-IC21 macrophages remained the same (Fig. 1I) ; however, fewer TNTs were observed ( Fig. 1J ; 30% decrease, p < .05). A more pronounced difference was observed when TNTs containing cystinosin-bearing vesicles were exclusively quantified using CTNS-eGFP-IC21 macrophages ( Fig. 1J ; 55% lower, p 5 .001). These data showed that Ctns-deficient cells triggered nanotube formation, especially the thick TNTs involved in cystinosin transfer. These data are consistent with previous reports indicating that "cellular stress" significantly enhanced TNT formation and organelle transfer [35, 36] . As macrophages and fibroblasts are plated for coculture at a low density so that cells are not in physical contact, the hypothesis is that Ctns 2/2 fibroblasts, because of their defects, secrete in the culture media factors stimulating the generation of TNTs.
TNT-Mediated Lysosomal Transfer is Bidirectional
Having found that cystinosin-bearing lysosomes can use TNTs to reach the cytoplasm of Ctns-deficient cells, we conversely investigated whether defective (cystine-loaded) lysosomes from deficient fibroblasts could also use TNTs to enter the cytoplasm of macrophages. Our bifluorescent assay revealed numerous DsRed-positive vesicles within the eGFP-macrophages (Supporting Information Fig. S2C ), suggesting that vesicular transfer via TNTs may indeed be bidirectional. To test this hypothesis, Ctns 2/2 fibroblasts stably expressing a Lamp1 (Lysosomal-associated membrane protein 1)-DsRed fusion protein were cocultured with CTNSeGFP-macrophages. Time-lapse confocal imaging confirmed bidirectional transfer of cystinosin-and Lamp1-vesicles along the same TNT ( Fig. 2A and Supporting Information Video S3), that is, not only cystinosin-eGFP-containing vesicles migrating toward Ctns-deficient cells (Fig. 2B ) but also cystinosin-deficient Lamp1-DsRed lysosomes/endosomes being transferred to the macrophages (Fig. 2C) . Lysosomes are dynamic organelles that distribute load by fusion/fission [37] . We thus suggest that active bidirectional lysosomal exchange followed by fusion with the large 
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lysosome pool of cell bodies in the two populations enhances cystine clearance, which probably contributes to the robust decrease in cystine levels observed in all tissues of HSC-transplanted cystinotic mice (57%-94% clearance), despite the limited integration of bone marrow-derived cells within tissues (5%-19%) [9] . HSCs lentivirally transduced to express cystinosin-eGFP (C, D), after labeling for F-actin (phalloidin, magenta, C) or megalin immunolabeling to identify the brush border of proximal tubules (magenta, D). Engrafted DsRed-expressing bone marrowderived macrophages surrounding kidney tubules contain eGFP-positive discrete vesicles (arrowheads; C and D) or enlarged structures (arrow; C), probably due to clustering and/or fusion of lysosomes due to CTNS over-expression, as previously described [8, 38] . 
In Vivo Cystinosin Transfer from HSC-Mediated Macrophages
Very little is known about TNTs in vivo. We thus examined whether intercellular vesicular exchange involving nanotubules or similar cellular extensions could be detected in vivo, so as to account for the efficacy of HSC grafting in Ctns 2/2 mice.
As proof-of-concept, we focused on the kidney since (a) it represents a particularly challenging tissue for stem cell therapy, because of the formidable TBM barrier enclosing targeted PTCs [21, 22] ; (b) the earliest occurrence of cystinosis in PTCs is a major clinical concern; and (c) the mechanism of HSCmediated renal repair is much debated [39, 40] . Conventional confocal microscopy analysis of kidneys of bifluorescent grafted mice at 6 months post-transplantation revealed abundant bone marrow-derived cells closely surrounding, but never within, the proximal tubules (Supporting Information  Fig. S1E, S1F ). However, careful high-resolution examination of fields with grazing BM sections revealed numerous tubular extensions emanating from engrafted eGFP-expressing HSCderived macrophages that penetrated and even crossed the TBM (Fig. 3Aa-3Ac and Supporting Information Videos S4A, S4B). Several tubular extensions could be generated by each macrophage, connecting with several Ctns 2/2 tubular cells, probably accounting for the robust cystine decrease despite limited bone marrow-derived cells present in the tissues [9] . Enlarged tips were reminiscent of those seen in vitro (Fig. 1C) and appeared overall quite comparable to invadopodia [23, 24] . We speculate that epithelial stress in Ctns 2/2 PTCs ( Fig.   3Aa and [41] ) promotes TNT/invadopodia formation. As a nonmutually exclusive mechanism, disorganized TBM due to epithelial disease might favor TNTs/invadopodia permeation. Furthermore, eGFP-containing structures were observed within PTCs, indicating physical transfer of cytoplasm from the macrophages into the epithelia (Fig. 3Ac) . To test this hypothesis, we analyzed Ctns 2/2 mice transplanted with DsRedCtns 2/2 HSCs stably expressing cystinosin-eGFP fusion protein (Fig. 3C, 3D ) or with control DsRed-Ctns 2/2 HSCs (Fig. 3B) .
Numerous cystinosin-eGFP-containing vesicles were observed in PTCs (Fig. 3C, 3D ), directly demonstrating epithelial cell crosscorrection and likely accounting for the long-term kidney preservation in Ctns 2/2 mice [10] . To our knowledge, this is the first evidence of direct transfer of proteins from interstitial macrophages to epithelial cells via TNTs/invadopodia penetrating the TBM, so as to correct a genetic defect leading to PTC degeneration.
CONCLUSIONS
We describe here a new mechanism by which HSCs can lead to tissue repair in the context of a lysosomal storage disorder. These findings show that HSC transplantation holds not only potential to treat hematopoietic diseases but also nonhematopoietic disorders, even complex nephropathies. Sustained intercellular, bidirectional vesicular transfer after HSC transplantation, even across the formidable barrier of basement membranes, brings new perspectives to regenerative medicine. In principle, this strategy should be applicable to other lysosomal and even other organelle disorders in which curative therapy requires restoration of the functional protein in multiple tissue compartments, and for which HSC transplantation is yet to be considered.
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